Elizabeth Yan
About
Elizabeth Yan is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology.
According to data from OpenAlex, Elizabeth Yan has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 21 papers in Genetics and 16 papers in Oncology. Recurrent topics in Elizabeth Yan's work include Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (16 papers) and Meningioma and schwannoma management (11 papers). Elizabeth Yan is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (16 papers) and Meningioma and schwannoma management (11 papers). Elizabeth Yan collaborates with scholars based in United States, Canada and Australia. Elizabeth Yan's co-authors include Ian F. Parney, Ivy A. Petersen, Peter Forsyth, Glòria Roldán, Jan C. Buckner, Shota Tanaka, Angelique Sijben, Robert W. Mutter, Joon H. Uhm and Kent R. Bailey and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Cancer Research.
In The Last Decade
Elizabeth Yan
51 papers receiving 1.2k citations
Peers
Elizabeth Yan
David B. Mansur United States
Ricardo J. Komotar United States
Stefania Scarpino Italy
J. G. Cairncross Canada
David Kaul Germany
Shyam Tanguturi United States
Francesco Cicone Italy
James R. Fink United States
Frank T. Vertosick United States
Keiichi Magota Japan
Citations per year, relative to Elizabeth Yan Elizabeth Yan (= 1×)
peers
David B. Mansur
Countries citing papers authored by Elizabeth Yan
Since
Specialization
Citations
This map shows the geographic impact of Elizabeth Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Yan more than expected).
Fields of papers citing papers by Elizabeth Yan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Elizabeth Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Yan. The network helps show where Elizabeth Yan may publish in the future.
Co-authorship network of co-authors of Elizabeth Yan
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Yan. A scholar is included among the top collaborators of Elizabeth Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Yan. Elizabeth Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Breen, William G., Jesse G. Dixon, S. Keith Anderson, et al.. (2025). Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma. Neuro-Oncology. 27(10). 2661–2670.
2.
Meyer, Alain, William S. Harmsen, Thomas B. Bradley, et al.. (2025). Real-World Experience Using Proton Versus Photon Craniospinal Irradiation for Leptomeningeal Disease. Practical Radiation Oncology. 15(5). 472–480.
3.
Routman, David M., Ignacio Jusué-Torres, Paul D. Brown, et al.. (2024). Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial. BMC Cancer. 24(1). 332–332.
4.
Zaniletti, Isabella, William G. Breen, Anita Mahajan, et al.. (2024). Establishing the minimal clinically important difference of the Brief Fatigue Inventory for brain or CNS cancer patients undergoing radiotherapy. Neuro-Oncology Practice. 11(5). 633–639.
5.
Breen, William G., Mark R. Waddle, J. Qian, et al.. (2024). Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysis. Neuro-Oncology Advances. 6(1). vdae034–vdae034.
6.
Merrell, Kenneth W., Derek R. Johnson, Michael W. Ruff, et al.. (2024). A Prospective, Phase II Study of 177Lu-Dotatate in Patients with Surgery- and Radiation-Refractory Meningioma: Results of the WHO Grade II/III Cohort. International Journal of Radiation Oncology*Biology*Physics. 120(2). S11–S12.
7.
Gandara, David R., et al.. (2024). 1853P Risk model for overall survival (OS) based on composite patient-reported outcomes (PROs) in aNSCLC patients treated with first-line (1L) cemiplimab-based therapy. Annals of Oncology. 35. S1092–S1092.
8.
Ang, Jann C., Angela Huynh, Barbara Baker, et al.. (2023). Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis. Scientific Reports. 13(1). 22846–22846.
9.
Gandara, David R., Ahmet Sezer, Mahmut Gümüş, et al.. (2023). MA05.11 Predictive Utility of Patient-Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3. Journal of Thoracic Oncology. 18(11). S117–S117.
10.
Shiraishi, Satomi, Nicholas B. Remmes, William S. Harmsen, et al.. (2022). Intensity Modulated Proton Therapy for Bilateral Breast or Chest Wall and Comprehensive Nodal Irradiation for Synchronous Bilateral Breast Cancer: Initial Clinical Experience and Dosimetric Comparison. Advances in Radiation Oncology. 7(3). 100901–100901.
11.
Laack, Nadia N., Deanna Pafundi, S. Keith Anderson, et al.. (2021). Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 110(5). 1383–1395.
12.
Hasegawa, Hirotaka, Kunal Vakharia, Michael J. Link, et al.. (2021). The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience. Journal of Neuro-Oncology. 155(3). 335–342.
13.
Ahmed, Safia K., Sean S. Park, Ivy A. Petersen, et al.. (2020). Reirradiation for Locoregional Recurrent Breast Cancer. Advances in Radiation Oncology. 6(1). 100640–100640.
14.
Mutter, Robert W., Sean S. Park, Tina J. Hieken, et al.. (2018). Carbon Fiducial Image Guidance Increases the Accuracy of Lumpectomy Cavity Localization in Radiation Therapy for Breast Cancer. Practical Radiation Oncology. 9(1). e14–e21.
15.
Mutter, Robert W., Nicholas B. Remmes, Mohamed M. Kahila, et al.. (2016). Initial clinical experience of postmastectomy intensity modulated proton therapy in patients with breast expanders with metallic ports. Practical Radiation Oncology. 7(4). e243–e252.
16.
Jethwa, Krishan R., Mohamed M. Kahila, Katie N. Hunt, et al.. (2016). Delineation of Internal Mammary Nodal Target Volumes in Breast Cancer Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 97(4). 762–769.
17.
Novotny, Paul J., Ivy A. Petersen, Yolanda I. Garces, et al.. (2015). Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis. International Journal of Radiation Oncology*Biology*Physics. 92(3). 650–658.
18.
Cheville, Andrea, Debra H. Brinkmann, Jolanta M. Durski, et al.. (2013). The Addition of SPECT/CT Lymphoscintigraphy to Breast Cancer Radiation Planning Spares Lymph Nodes Critical for Arm Drainage. International Journal of Radiation Oncology*Biology*Physics. 85(4). 971–977.
19.
Tanaka, Shota, Fredric B. Meyer, Jan C. Buckner, et al.. (2012). Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma. Journal of Neuro-Oncology. 110(2). 227–235.
20.
Stafinski, Tania, Gian S. Jhangri, Elizabeth Yan, & Devidas Menon. (2006). Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: A systematic review and meta-analysis. Cancer Treatment Reviews. 32(3). 203–213.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by David B. Mansur Breakdown of academic impact, for papers by Ricardo J. Komotar Breakdown of academic impact, for papers by Stefania Scarpino Breakdown of academic impact, for papers by J. G. Cairncross Breakdown of academic impact, for papers by David Kaul Breakdown of academic impact, for papers by Shyam Tanguturi Breakdown of academic impact, for papers by Francesco Cicone Breakdown of academic impact, for papers by James R. Fink Breakdown of academic impact, for papers by Frank T. Vertosick Breakdown of academic impact, for papers by Keiichi Magota